Latest Asx Listings News

Elanor Commercial Property Fund’s Independent Board Committee has unanimously recommended rejecting Lederer Group’s unsolicited $0.70 per security takeover offer, citing significant undervaluation and strategic risks. The committee advises securityholders to take no action until a detailed target’s statement is released.

Latitude 66 Limited has responded to an ASX price query concerning unusual trading activity, confirming no undisclosed material information exists and referencing prior announcements about a joint venture sale and recent assay results.

Wagners Holding Company Limited has secured $30 million through a strongly supported placement to fund growth in its construction materials and composite fibre technologies divisions.

EMU NL has announced a non-renounceable entitlement offer to raise approximately $1.83 million to fund exploration at its Georgetown and Badja projects, while facing significant governance challenges ahead of a pivotal shareholder meeting.

333D Limited has ended its voluntary suspension, confirming its Bitcoin acquisitions align with ASX rules and outlining a disciplined treasury management strategy to support operational cash flow and growth.

Barton Gold Holdings has upgraded its Challenger Gold Project resource to over 300,000 ounces of gold and is advancing feasibility studies targeting production by the end of 2026. The company plans a phased approach starting with tailings reprocessing before fresh rock mining.

Metal Powder Works Limited has completed a A$15 million institutional placement, strengthening its balance sheet to scale production and expand its market presence.

Samuel Terry Asset Management has launched an off-market takeover offer for all Eildon Capital Group stapled securities at A$0.80 per security, representing a notable premium over recent trading prices. The move aims to consolidate ownership and potentially delist Eildon Capital from the ASX.

Pathkey.AI’s TrialKey platform has demonstrated a 73% alignment with actual biotech trial outcomes, showing an average hypothetical share price gain of 76%, underscoring AI’s growing role in clinical trial prediction and biotech investing.

Harvey Norman Holdings Limited has responded to ASX inquiries confirming its FY25 earnings aligned with market expectations, despite the absence of formal guidance and complexities in analyst forecasting.

iTech Minerals has responded to ASX concerns, confirming it disclosed material information on its Bayonet, Sabre, and Falchion prospects promptly and in compliance with listing rules.

Matsa Resources has entered an underwriting agreement to guarantee the exercise of up to 10 million unlisted options expiring this September, potentially raising $700,000 in fresh capital.